MRNA - Marina Biotech, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development907.493132.513322.317
Selling General and Administrative4,732.221576.028785.261
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-6,090.617-757.73-1,107.578
Income from Continuing Operations
Total Other Income/Expenses Net-49.041-75.1-75.1
Earnings Before Interest and Taxes-6,139.658-832.83-1,106.964
Interest Expense78.893.5133.513
Income Before Tax-6,218.548-836.343-1,106.964
Income Tax Expense0.80.81.6
Minority Interest---
Net Income From Continuing Ops-6,219.348-837.143-1,108.564
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-6,219.348-837.143-1,108.564
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-6,219.348-837.143-1,108.564